These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26162947)

  • 1. Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.
    Nakatani Y; Sakamoto T; Nishida K; Kataoka N; Yamaguchi Y; Sakabe M; Fujiki A; Mizumaki K; Inoue H
    J Cardiol; 2015 Nov; 66(5):445-50. PubMed ID: 26162947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
    Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H
    Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.
    Fujiki A; Sakamoto T; Iwamoto J; Nishida K; Nagasawa H; Mizumaki K; Inoue H
    Circ J; 2006 Sep; 70(9):1138-41. PubMed ID: 16936425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine.
    Fujiki A; Sakabe M; Nishida K; Sugao M; Tsuneda T; Iwamoto J; Mizumaki K; Inoue H
    Circ J; 2004 Dec; 68(12):1139-45. PubMed ID: 15564697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model.
    Fukaya H; Niwano S; Niwano H; Masaki Y; Kiryu M; Hirasawa S; Sato D; Moriguchi M; Izumi T
    Int J Cardiol; 2012 May; 157(2):197-206. PubMed ID: 21193236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhomogenic effect of bepridil on atrial electrical remodeling in a canine rapid atrial stimulation model.
    Fukaya H; Niwano S; Satoh D; Masaki Y; Niwano H; Kojima J; Moriguchi M; Izumi T
    Circ J; 2008 Feb; 72(2):318-26. PubMed ID: 18219173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.
    Chiba T; Kondo N; Takahara A
    J Pharmacol Sci; 2016 Mar; 130(3):170-6. PubMed ID: 27032905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model.
    Sato D; Niwano S; Imaki R; Masaki Y; Sasaki S; Yuge M; Hirasawa S; Sasaki T; Moriguchi M; Niwano H; Yoshimura H; Izumi T
    Circ J; 2006 Feb; 70(2):206-13. PubMed ID: 16434817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide suppresses atrial electrophysiological changes.
    Nakamura H; Niwano S; Niwano H; Fukaya H; Murakami M; Kishihara J; Satoh A; Yoshizawa T; Ishizue N; Igarashi T; Fujiishi T; Ako J
    Heart Vessels; 2019 Aug; 34(8):1389-1393. PubMed ID: 30762094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.
    Sakamoto T; Fujiki A; Nakatani Y; Sakabe M; Mizumaki K; Hashimoto N; Inoue H
    Circ J; 2009 Oct; 73(10):1820-8. PubMed ID: 19713653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological cardioversion of long-lasting atrial fibrillation.
    Fujiki A; Inoue H
    Circ J; 2007; 71 Suppl A():A69-74. PubMed ID: 17587743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study of the effect of the vagus nerve on atrial electrical remodeling.
    Huang CX; Zhao QY; Jiang H; Li JJ; Yang B
    J Electrocardiol; 2003 Oct; 36(4):295-300. PubMed ID: 14661165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tachycardia.
    Nishida K; Fujiki A; Sakamoto T; Iwamoto J; Mizumaki K; Hashimoto N; Inoue H
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):765-72. PubMed ID: 17472715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
    Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
    J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model.
    Kojima J; Niwano S; Moriguchi M; Ikeda K; Inuo K; Saito J; Izumi T
    Circ J; 2003 Apr; 67(4):340-6. PubMed ID: 12655166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm.
    Fujiki A; Tsuneda T; Sugao M; Mizumaki K; Inoue H
    Am J Cardiol; 2003 Aug; 92(4):472-5. PubMed ID: 12914884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hybrid therapy using prior administration of bepridil hydrochloride and cryoballoon ablation in patients with persistent atrial fibrillation.
    Yakabe D; Aso A; Araki M; Murasato Y; Nakamura T
    J Cardiol; 2020 Apr; 75(4):360-367. PubMed ID: 31540839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal stimulation promotes atrial electrical remodeling induced by rapid atrial pacing in dogs: evidence of a noncholinergic effect.
    Yang D; Xi Y; Ai T; Wu G; Sun J; Razavi M; Delapasse S; Shurail M; Gao L; Mathuria N; Elayda M; Cheng J
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1092-9. PubMed ID: 21793861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation.
    Yoshizawa T; Niwano S; Niwano H; Tamaki H; Nakamura H; Igarashi T; Oikawa J; Satoh A; Kishihara J; Murakami M; Fukaya H; Ako J
    Int Heart J; 2018 Sep; 59(5):1077-1085. PubMed ID: 30158379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.